Boehringer Ingelheim
Nima Soleymanlou is a seasoned professional with extensive experience in clinical development within the cardiovascular and metabolic therapeutic areas. Currently serving as Senior Director and Global Medical Lead at Boehringer Ingelheim since 2007, Nima has demonstrated expertise in medical leadership and management of global clinical programs. Previous roles include Director of Clinical Development and Therapeutic Area Specialist, focusing on overseeing Canadian clinical research teams and managing complex phase 2 and phase 3 clinical trials. Prior to Boehringer Ingelheim, Nima held positions at ratiopharm, Mount Sinai Hospital, and PerkinElmer, contributing to significant advancements in clinical studies and research. Nima holds a Doctorate from the University of Toronto's Faculty of Medicine, along with a Master's in Drug Research and a Bachelor's in Immunology from the same institution.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.